ArticleEuropean journal of applied physiology2026
Variable intensity interval training improves cardiorespiratory fitness and quality of life across Hashimoto's stages and lowers TSH in subclinical patients: a 12-week supervised study.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the effects of variable intensity interval training (VIIT) on thyroid function, body composition, cardiorespiratory fitness, and quality of life (QoL) in women with Hashimoto's thyroiditis (HT) at different stages of disease progression.
methodsThirty-one women (aged 18-65) with confirmed Hashimoto's thyroiditis were assigned to three groups: euthyroid (n = 10), subclinical (n = 11), and clinical (n = 10). The 12-week supervised intervention consisted of VIIT combining higher and moderate-intensity intervals. Markers of thyroid function and autoimmunity were assessed via blood analysis. Body composition was measured by bioelectrical impedance, cardiorespiratory fitness by a graded exercise test on a cycle ergometer, and quality of life using the SF-36 questionnaire. Intervention effects were evaluated using a two-factor repeated-measures ANOVA (time × group).
resultsThe subclinical HT group showed a significant reduction in thyroid-stimulating hormone (TSH; -32%, p < 0.01; Cohen's d = 1.03), while no hormonal or antibody changes were observed in the other groups. Both the subclinical and clinical groups showed significant reductions in body mass and BMI (p < 0.05), whereas body fat percentage decreased only in the subclinical group. All groups demonstrated a significant increase in maximal oxygen uptake (VO₂max; 13-22%, p < 0.05). Improvements in several quality-of-life domains were observed following the intervention, particularly in the subclinical and clinical groups (p < 0.05).
conclusionVIIT may advance thyroid function in women with subclinical HT and improve cardiorespiratory fitness, body composition and QoL across all stages of the disease.
Indexed as
Identifiers
42545478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.